Project Grant R37AI136697
- This $536,943.46 Project Grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases funds research at The Scripps Research Institute-Florida on identifying host factors that regulate HIV latency and reactivation. The grant supports three aims over a six-month period: defining the roles of proteins P32, FUBP3, and PHB2 in HIV transcription and chromatin structure; investigating protein complexes associated with P32, FUBP3, and PHB2 and their interaction...
- This $823,691 Project Grant award was provided by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) to investigate the role of immune checkpoints in the central nervous system (CNS) of people living with HIV (PLWH) and their association with HIV-associated neurocognitive disorder (HAND). The research aims to determine the profiles and biological functions of soluble immune checkpoints (sICPs) in the CNS of PLWH and a simian immunodeficiency...
- Federal Grant Award Summary The University of Iowa received a $769,414 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 9, 2025, with an ultimate completion date of June 30, 2030. This research award funds investigation into how the cellular protein SAMHD1 (sterile alpha motif and HD domain-containing protein 1) regulates innate immune responses during Human...
- This $564,001 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research on membrane-associated RING CH (MARCH) proteins and their role in restricting HIV-1 infection. MARCH proteins are a family of ubiquitin ligases that regulate membrane receptors and have been shown to restrict HIV-1 and other retroviruses by blocking viral envelope incorporation into budding virions. The research foundation for the State University of New...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded $852,121.24 to The Scripps Research Institute-Florida under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period of July 22, 2021 through October 31, 2021. The project aims to identify host factors that regulate HIV latency and reactivation in order to develop strategies for durable HIV silencing. The grantee will define the roles of three identified host factors, P32,...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Salk Institute for Biological Studies a Project Grant of $188,208 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for structural and biochemical studies of human immunodeficiency virus (HIV) and mouse mammary tumor virus (MMTV) retroviral integration. The award, obligated on October 24, 2025, with completion scheduled for June 30, 2028, supports research to elucidate...
- This $624,902 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research to investigate how the HIV accessory protein Vpr induces epigenetic remodeling in myeloid cells, which may contribute to HIV persistence. The research aims to characterize the functional impact of Vpr-directed epigenetic remodeling on the HIV promoter during acute infection and latency reactivation, delineate the mechanisms of...
- The University of Utah's Office of Sponsored Projects received a $150,104 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective January 22, 2026, through August 31, 2028. This fellowship award (F32 postdoctoral award) funds research designed to elucidate the mechanistic role of HIV-1 integrase (IN) in viral maturation and RNA encapsidation. The research employs complementary...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $698,390 to the Regents of the University of California at Riverside under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program on August 1, 2025. The project, titled "Harnessing Innate Immunity to Control the Neuroinflammatory HIV Reservoir," will be completed by June 30, 2030. This research initiative investigates how...
- The National Institute on Aging (NIA), through its Aging Research program (CFDA 93.866), has awarded a $534,644.00 Project Grant to Temple University - Of The Commonwealth System Of Higher Education. The grant aims to characterize how the HIV-1 virus decreases neuronal clearance, leading to the progression of HIV-associated neurocognitive disorders like motor dysfunction. Key research activities include determining the post-translational regulation of the SNAPIN protein and its impact on...
BIOCHEMISTRY OF SAMHD1-MEDIATED INNATE IMMUNITY RESPONSES - ABSTRACT SAMHD1 IS A HUMAN IMMUNE FACTOR THAT IMPEDES INFECTION OF MYELOID CELLS AND RESTING T LYMPHOCYTES BY HIV- 1. SAMHD1 IS A DEOXYNUCLEOTIDE TRIPHOSPHATE HYDROLASE (DNTPASE), AND THE DISCOVERY OF ITS ANTI-RETROVIRAL ACTIVITY BROUGHT TO LIGHT A NOVEL ANTIVIRAL MECHANISM THAT DEPENDS ON THE ENZYMATICALLY CONTROLLED DEPLETION OF CELLULAR DNTP POOLS. THE ABILITY OF IMMUNE CELLS TO USE DNTP DEPLETION FOR ANTIVIRAL DEFENSE IS PUZZLING, BECAUSE EVEN QUIESCENT AND TERMINALLY DIFFERENTIATED CELLS REQUIRE DEOXYNUCLEOTIDES FOR DNA REPAIR AND MITOCHONDRIAL BIOGENESIS. SAMHD1 IS A KEY REGULATOR OF DNTP CONCENTRATIONS IN NONPROLIFERATING CELLS AND BETTER UNDERSTANDING OF ITS ENZYMATIC PROPERTIES MAY SHED LIGHT ON THE TANTALIZING RELATIONSHIP BETWEEN DNTP METABOLISM AND ANTIVIRAL IMMUNITY. OUR RECENT WORK REVEALED THAT THE 'FACILITATED DNTP DEPLETION' FUNCTION OF SAMHD1 ARISES FROM ITS ALLOSTERIC ACTIVATION MECHANISM, A TWO-STEP PROCESS INVOLVING TETRAMER ASSEMBLY AND SUBSEQUENT ACTIVATION. FACILITATED DNTP DEPLETION ENABLES REGULATORY CROSSTALK BETWEEN BIOSYNTHESIS AND DEPLETION OF DIFFERENT DNTPS AND MANIFESTS AS MORE ROBUST DEPLETION OF SOME NUCLEOTIDES WHEN BIOSYNTHESIS OF CERTAIN OTHERS IS ELEVATED. WE HYPOTHESIZE THAT THE ALLOSTERIC REGULATION OF SAMHD1 IS A KEY COMPONENT TO THE CELLULAR DECISION-MAKING MECHANISM THAT CONTROLS THE SWITCHING BETWEEN MULTIPLE DISCRETE STATES OF CELLULAR DNTP METABOLISM IN NONPROLIFERATING IMMUNE CELLS AND THUS DETERMINES WHETHER AND WHEN THESE CELLS BECOME NON-PERMISSIVE TO HIV INFECTION. IN THIS PROJECT WE SEEK TO ADVANCE OUR UNDERSTANDING OF HOW ALLOSTERIC AND POSTTRANSLATIONAL REGULATION OF SAMHD1 ENABLES DISTINCT STATES OF DNTP METABOLISM BY PURSUING TWO SPECIFIC AIMS. IN AIM 1 WE WILL DELINEATE HOW ENZYMATIC PROPERTIES OF SAMHD1 GIVE RISE TO THE ANTIVIRAL MODALITIES OF DNTP HOMEOSTASIS AND ENABLE IMMUNE AND METABOLIC DECISION-MAKING. WE ALSO SEEK TO ESTABLISH MECHANISTIC RELATIONSHIPS BETWEEN THE DISTINCT STATES OF CELLULAR DNTP METABOLISM AND THE SUSCEPTIBILITY TO HIV INFECTION. IN AIM 2 WE WILL ELUCIDATE THE STRUCTURAL BASIS OF ALLOSTERIC AND POSTTRANSLATIONAL REGULATION OF SAMHD1. OUR RECENT FINDINGS REVEAL THAT SAMHD1 ACTIVATION BY DNTP SUBSTRATES INVOLVES AN INACTIVE TETRAMERIC INTERMEDIATE WITH PARTIAL DNTP OCCUPANCY OF THE ALLOSTERIC SITES. HERE WE WILL FURTHER ELUCIDATE THE CONFORMATIONAL REPERTOIRE OF SAMHD1 ACTIVATION AND HOW IT IS MODULATED BY POSTTRANSLATIONAL MODIFICATIONS, NUCLEIC ACID LIGANDS AND PATHOGENIC MUTATIONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $556.3k | 5/14/25 | ||
| Not listed | $556.3k | 5/14/25 | ||
| Not listed | $736.7k | 2/25/25 | ||
| Not listed | $180.4k | 2/25/25 | ||
| Not listed | $55.6k | 9/5/24 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
175916175915S | Albert Einstein College Of Medicine, Inc. | Project Grant R37AI136697 | $167.8k | 3/4/26 |